Unisys Research on Trustworthy AI Published in Frontiers in Pharmacology Journal
Peer-reviewed study explores how neurosymbolic AI can improve trust and explainability with emerging technologies in healthcare and other regulated industries BLUE BELL, Pa., Sept. 2, 2026 /PRNewswire/ -- Unisys (NYSE: UIS) announces the publication of its peer-reviewed research paper, "From benchmark accuracy to pharmacological credibility: why mechanistic explainability must define the next generation of AI for drug repurposing," in Frontiers in Pharmacology, a leading journal from Frontiers Media.